leisure time -WSS

leisure time

author：leisure time 2025-09-30 16:27:36 - browse：8253

Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Another man arrested in connection with shooting at Kansas nightclub

WSS

Sen. Bill Cassidy on how to lower drug prices

Kellogg’s is going to war over Mexico’s nutrition label rules

Meadows told special counsel he could not recall Trump ever declassifying Mar

Intellia plays down concerns on accidental germline transmission

CDC says it’s too soon to assess risk posed by Covid subvariant

How the first Native Hawaiian psychiatrist helped diversify medicine

hotspot

leisure time

focus

Guidelines to prevent youth baseball injuries need more muscle

Kellogg’s is going to war over Mexico’s nutrition label rules

Apple is now the first public company to be valued at $3 trillion

Trans patients at the end of life deserve respect and dignity

Continuity nursing helped my family in our darkest PICU moments

FDA greenlights medical device to combat bladder issues

Jerome Adams on the need for new antivirals for Covid

Meadows told special counsel he could not recall Trump ever declassifying Mar

Bright Health sells Medicare Advantage business to Molina

Intellia plays down concerns on accidental germline transmission

hotspot

What to know about a major upcoming Wegovy heart health study

Intellia plays down concerns on accidental germline transmission

Wegovy improves function in certain heart failure patients

Another man arrested in connection with shooting at Kansas nightclub

As obesity drug market grows, telehealth companies court payers

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

leisure time

hotspot

entertainment

leisure time